The radioprotection of salivary glands by vitamin C and sodium bicarbonate in 131I treatment of patients with differentiated thyroid carcinoma

被引：0
作者：
Tong, Huimin [1 ]
Gao, Ying [1 ]
Zhang, Xiaomin [1 ]
Li, Xiaoqian [1 ]
Luo, Liping [1 ]
Huang, Nan [1 ]
Hu, Tingting [1 ]
An, Jie [1 ]
Wang, Jin [1 ]
Cheng, Yan [1 ]
机构：
[1] Shanxi Med Univ, First Hosp, Taiyuan, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1696
引用
收藏
页数：6
相关论文
共 50 条
[41]   Red marrow and blood dosimetry in 131I treatment of metastatic differentiated thyroid carcinoma: comparison in patients with repeated treatments [J].
Richetta, E. ;
Pasquino, M. ;
Cutaia, C. ;
Giostra, A. ;
Pellerito, R. ;
Stasi, M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 :S220-S220
[42]   Staging of Differentiated Thyroid Carcinoma Using Diagnostic 131I SPECT/CT [J].
Wong, Ka Kit ;
Sisson, James C. ;
Koral, Kenneth F. ;
Frey, Kirk A. ;
Avram, Anca M. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (03) :730-736
[43]   Iodine biokinetics and 131I absorbed dose in metastatic differentiated thyroid carcinoma [J].
Liu, Bin ;
Kuang, Anren .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
[44]   Impact of 131I SPECT/CT Imaging on the Management of Differentiated Thyroid Carcinoma [J].
Vercosa, A. F. A. ;
Amorim, B. J. ;
Mosci, C. ;
Lima, M. C. L. ;
Etchebehere, E. C. S. C. ;
Santos, A. O. ;
Assumpcao, L. V. M. ;
Zantut-Wittmann, D. E. ;
Ramos, C. D. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 :S556-S557
[45]   Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma [J].
Jung-Jun Min ;
June-Key Chung ;
Yong Lee ;
Jae Jeong ;
Dong Lee ;
Ja Jang ;
Myung Lee ;
Bo Cho .
European Journal of Nuclear Medicine, 2001, 28 :639-645
[46]   Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma [J].
Min, JJ ;
Chung, JK ;
Lee, YJ ;
Jeong, JM ;
Lee, DS ;
Jang, JJ ;
Lee, MC ;
Cho, BY .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (05) :639-645
[47]   Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan? [J].
Salvatori, M ;
Perotti, G ;
Rufini, V ;
Maussier, ML ;
Dottorini, M .
CLINICAL ENDOCRINOLOGY, 2004, 61 (06) :704-710
[48]   Empiric 131I Treatment of High Thyroglobulin Levels in Differentiated Thyroid Carcinoma After Remmant Ablation [J].
Kalender, E. ;
Elboga, U. ;
Celen, Y. ;
Demir, H. ;
Sahin, E. ;
Yilmaz, M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 :S503-S503
[49]   Incidence of Nonthyroidal Primary Malignancy and the Association with 131I Treatment in Patients with Differentiated Thyroid Cancer [J].
Hirsch, Dania ;
Shohat, Tzippy ;
Gorshtein, Alex ;
Robenshtok, Eyal ;
Shimon, Ilan ;
Benbassat, Carlos .
THYROID, 2016, 26 (08) :1110-1116
[50]   Curative Efficacy and Influencing Factors on 131I Treatment for Pulmonary Metastases from Differentiated Thyroid Carcinoma [J].
Xu, Z. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 :S601-S602
12345